Tyra Biosciences, Inc.
TYRA
Revenue
0.00
0.000.00%
-Assets
392.46M
▼-12.28M▼-3.03%
3 Months ChangeLiabilities
16.42M
▲1.56M▲10.47%
3 Months ChangeFree Cash Flow
-22.16M
▼-12.28M▼-124.15%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-28
Form 8-K
ID: 0001193125-24-244590
2024-10-25
Form 8-K
ID: 0001193125-24-243475
2024-10-18
Form 8-K
ID: 0001193125-24-239650
2024-08-07
Form 10-Q
ID: 0000950170-24-092778
2024-08-07
Form 8-K
ID: 0000950170-24-092756
2024-05-31
Form 8-K
ID: 0001193125-24-151705
2024-05-09
Form 10-Q
ID: 0000950170-24-056971
2024-05-09
Form 8-K
ID: 0000950170-24-056935
2024-05-07
Form 8-K
ID: 0001193125-24-133170
2024-03-19
Form 8-K
ID: 0000950170-24-033455